White-coat hypertension and cardiovascular events: A meta-analysis

Journal of Hypertension

Volumn 34, Issue 4, 2016, Pages 593-599

  Briasoulis, Alexandros ^a   Androulakis, Emmanuel ^b   Palla, Mohan ^a   Papageorgiou, Nikolaos ^a,c   Tousoulis, Dimitris ^d  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

blood pressure control; cardiovascular events; white coat hypertension

Indexed keywords

BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; FOLLOW UP; HOME MONITORING; HUMAN; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLISHING; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; WHITE COAT HYPERTENSION; AGED; CARDIOVASCULAR DISEASES; COMPLICATION; META ANALYSIS; MIDDLE AGED;

AGED; CARDIOVASCULAR DISEASES; HUMANS; MIDDLE AGED; WHITE COAT HYPERTENSION;

EID: 84960409518     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000832     Document Type: Review

References (26)

1. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1105-1187.
2. Asayama K, Thijs L, Li Y, Gu YM, Hara A, Liu YP, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension 2014; 64:935-942.
3. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White-coat hypertension. Lancet 1996; 348:1444-1445.
4. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000; 102:1139-1144.
5. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with whitecoat and sustained hypertension. J Am Coll Cardiol 2001; 38:238-245.
6. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 2003; 17:811-817.
7. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
8. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-Term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853.
9. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-Analysis. Am J Hypertens 2011; 24:52-58.
10. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of masked hypertension and white-coat hypertension detected by 24-h ambulatory blood ressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46:508-515.
11. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-Analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012; 59:564-571.
12. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G. Long-Term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension 2013; 62:168-175.
13. Hermida RC, Ayala DE, Mojón A, Fernández JR. Sleep-Time blood pressure and the prognostic value of isolated-office and masked hypertension. Am J Hypertens 2012; 25:297-305.
14. Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension 2014; 63:675-682.
15. Hänninen MR, Niiranen TJ, Puukka PJ, Johansson J, Jula AM. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. J Hypertens 2012; 30:705-712.
16. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98:1892-1897.
17. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al. IDACO Investigators. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-Analysis of 7030 individuals. J Hypertens 2007; 25:1554-1564.
18. Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F. Short- and long-Term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens 2008; 22:408-414.
19. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14:327-334.
20. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682-1686.
21. Sung SH, Cheng HM, Wang KL, Yu WC, Chuang SY, Ting CT, et al. White coat hypertension is more risky than prehypertension: important role of arterial wave reflections. Hypertension 2013; 61:1346-1353.
22. Manios ED, Koroboki EA, Tsivgoulis GK, Spengos KM, Spiliopoulou IK, Brodie FG, et al. Factors influencing white-coat effect. Am J Hypertens 2008; 21:153-158.
23. Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Is whitecoat hypertension a risk factor for carotid atherosclerosis? A review and meta-Analysis. Blood Press Monit 2015; 20:57-63.
24. Schillaci G, Pucci G, Pirro M. Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension. J Hypertens 2011; 29:869-875.
25. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-Term incidence of stroke in white-coat hypertension. Hypertension 2005; 45:203-208.
26. Palatini P, Mormino P, Santonastaso M. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31:57-63.